Highlights

  • Kogan.com shares jumped 18.31% after reporting higher sales, expanding margins, and improving Earnings momentum.
  • Fisher & Paykel Healthcare climbed 9.41% following double-digit Revenue and profit growth alongside upgraded FY27 expectations.
  • NRW Holdings gained 3.06% after announcing approximately AUD 120 million in new infrastructure and electrical contracts through Fredon.

Three ASX-listed companies — Kogan.com Ltd (ASX:KGN), Fisher & Paykel Healthcare Corporation Ltd (ASX:FPH), and NRW Holdings Ltd (ASX:NWH) — closed higher on Tuesday after releasing market updates that highlighted improving financial performance, contract wins, and operational expansion.

The companies operate across different sectors including E-commerce, healthcare technology, and infrastructure services, yet all three attracted investor attention after publishing announcements that pointed to revenue growth, profitability improvement, or increasing project pipelines.

Kogan.com shares closed 18.31% higher at AUD 4.07, Fisher & Paykel Healthcare rose 9.41% to AUD 30.12, while NRW Holdings added 3.06% to finish at AUD 7.42.

The positive market reaction reflected investor focus on earnings visibility, operational execution, and forward growth expectations during a period when investors remain selective about corporate updates and financial outlooks.

Kogan.com Shares Jumped After Earnings and Margin Improvement

Kogan.com recorded the largest gain among the three companies after releasing its May 2026 Business update covering the first 10 months of FY26.

The online retailer reported that gross sales increased 13.2% to AUD 875.6 million, while group revenue rose 6% to AUD 433.7 million. The company’s core Kogan.com business delivered even stronger momentum, with gross sales and revenue each increasing more than 18%.

Investors appeared particularly encouraged by the company’s earnings growth and expanding margins. Group adjusted EBITDA increased 17.4% to AUD 37.5 million, while adjusted EBIT rose 25.4% to AUD 26.9 million.

Within the core Kogan.com platform, adjusted EBITDA and adjusted EBIT increased 32% and 43.2% respectively compared with the prior corresponding period.

The company stated that stronger customer engagement, increasing active customers, and continued expansion in platform-based sales supported the performance.

Group active customers increased 4% to 3.5 million, while active customers on the Kogan.com platform rose 9%.

Another Factor that likely contributed to investor optimism was the improving performance of Mighty Ape, the company’s New Zealand Subsidiary. Management highlighted that Mighty Ape continued progressing toward profitability after restructuring initiatives aimed at transitioning the business toward a more Capital-light operating model.

Mighty Ape’s gross margin expanded by 1.3 percentage points during the reporting period. In the four months to 30 April 2026, gross margin increased 8.4 percentage points to 37.8%, while adjusted EBITDA losses reduced by 52.8%.

The market response suggested investors viewed the update as evidence that Kogan.com’s focus on Operating Leverage and cost discipline was beginning to translate into improved earnings quality.

The company also noted that group adjusted EBITDA margin reached 8.6%, tracking toward the upper end of previously issued FY26 guidance.

Fisher & Paykel Healthcare Advanced After FY26 Results

Fisher & Paykel Healthcare also recorded a significant gain after announcing full-year FY26 financial results that showed double-digit growth across revenue and profit metrics.

The healthcare technology company reported total Operating Revenue of NZD 2.31 billion, representing a 14% increase from the previous financial year. Net profit after tax increased 24% to NZD 468.5 million.

The company’s Hospital product group was a major contributor to growth, with revenue increasing 18% to NZD 1.51 billion. Hospital consumables revenue increased 16%, despite what management described as lower-than-expected seasonal respiratory illness admissions in some key global markets.

Investors appeared encouraged by management commentary indicating that changing clinical practices continued supporting Demand for the company’s respiratory and acute care products.

The Homecare division also contributed to growth, with revenue increasing 8% to NZD 802.7 million. Revenue from obstructive sleep apnea masks rose 7%, supported by continued uptake of the F&P Solo and F&P Nova mask ranges.

Management additionally highlighted positive market reception for the F&P Nova Nasal product launched in the United States earlier this year.

Gross margin increased to 63.7%, reflecting operational improvement initiatives despite the impact of US tariffs on hospital products sourced from New Zealand.

The market response also appeared linked to the company’s FY27 outlook. Fisher & Paykel Healthcare projected FY27 operating revenue in the range of approximately NZD 2.45 billion to NZD 2.57 billion, with net profit after tax expected between NZD 500 million and NZD 550 million.

The company stated that the outlook anticipates further improvement in gross margin despite Tariff-related pressures and geopolitical uncertainties linked to the Middle East conflict.

Investors also responded positively to the company’s Dividend increase. The final dividend was lifted to 33.0 cents per share, taking the total FY26 dividend to 52.0 cents per share, up 22% from the prior year.

NRW Holdings Rose Following New Contract Awards

NRW Holdings shares also finished higher after the company announced approximately AUD 120 million in new contracts secured by its Wholly Owned Subsidiary Fredon.

The contracts cover infrastructure, electrical, communications, and technology works across Victoria and Western Australia.

The largest contract involved an additional AUD 69 million electrical package tied to an existing data centre project in Victoria for Lendlease. Fredon’s total contract value at the site has now increased to approximately AUD 155 million.

The remaining contracts include work associated with the Bunbury Hospital Redevelopment in Western Australia, the University of Western Australia Nedlands Student Accommodation project, and the 609 Wellington Street Purpose Built Student Accommodation development in Perth.

The market reaction suggested investors interpreted the new contracts as a positive signal for NRW Holdings’ future revenue pipeline and infrastructure exposure.

The projects also highlighted the company’s Diversification beyond traditional Mining and civil contracting activities.

Fredon, part of NRW’s EMIT division, provides electrical, mechanical, infrastructure, technology, and maintenance services. The latest contract wins demonstrated continued demand across healthcare, education, student accommodation, and data centre infrastructure projects.

Management commentary accompanying the announcement emphasized Fredon’s ability to secure contracts involving critical infrastructure and live operational environments.

Investors often monitor contract announcements closely in the engineering and construction sector because they provide visibility into future workloads and earnings activity.

NRW Holdings’ diversified business structure across mining services, civil construction, industrial engineering, and infrastructure continues to provide exposure to multiple segments of the Australian economy.

Conclusion

Kogan.com, Fisher & Paykel Healthcare, and NRW Holdings all closed higher on Tuesday after releasing announcements that strengthened investor confidence in their respective growth trajectories. Kogan.com benefited from improving earnings and margin expansion, Fisher & Paykel Healthcare advanced after reporting higher revenue and profit alongside positive FY27 guidance, while NRW Holdings gained following approximately AUD 120 million in new infrastructure-related contracts. The market reaction highlighted investor preference for companies delivering measurable operational progress, expanding revenue visibility, and improving profitability metrics across different sectors of the ASX.